Hidenori Arai
Auto-generated profile, based on publicly available information

Hidenori Arai

National Center for Geriatrics and Gerontology

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
LCLiang-Kung Chen
Liang-Kung Chen
Jean WooJean Woo
Jean Woo
PAPrasert Assantachai
Prasert Assantachai
TATung-Wai Auyeung
Tung-Wai Auyeung
MCMing-Yueh Chou
Ming-Yueh Chou
HAHidenori Arai
Hidenori Arai

1 February 2014 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
LCLiang-Kung Chen
Liang-Kung Chen
LLLi-Kuo Liu
Li-Kuo Liu
Jean WooJean Woo
Jean Woo
PAPrasert Assantachai
Prasert Assantachai
TATung-Wai Auyeung
Tung-Wai Auyeung
HAHidenori Arai
Hidenori Arai

21 September 2014 in Age and Ageing
Verified
Journal Article
Open access
ACAlfonso J. Cruz-Jentoft
Alfonso J. Cruz-Jentoft
FLFrancesco Landi
Francesco Landi
Stéphane M. SchneiderStéphane M. Schneider
Stéphane M. Schneider
CZClemente Zúñiga
Clemente Zúñiga
HAHidenori Arai
Hidenori Arai
TCTommy Cederholm
Tommy Cederholm
Objective: to examine the clinical evidence reporting the prevalence of sarcopenia and the effect of nutrition and exercise interventions from studies using the consensus definition of sarcopenia proposed by the European Working Group on Sarcopenia in Older People (EWGSOP). Methods: PubMed and Dialog databases were searched (January 2000–October 2013) using pre-defined search terms. Prevalence studies and intervention studies investigating muscle mass plus strength or function outcome measures using the EWGSOP definition of sarcopenia, in well-defined populations of adults aged ≥50 years were selected. Results: prevalence of sarcopenia was, with regional and age-related variations, 1–29% in community-dwelling populations, 14–33% in long-term care populations and 10% in the only acute hospital-care population examined. Moderate quality evidence suggests that exercise interventions improve muscle strength and physical performance. The results of nutrition interventions are equivocal due to the low number of studies and heterogeneous study design. Essential amino acid (EAA) supplements, including ∼2.5 g of leucine, and β-hydroxy β-methylbutyric acid (HMB) supplements, show some effects in improving muscle mass and function parameters. Protein supplements have not shown consistent benefits on muscle mass and function. Conclusion: prevalence of sarcopenia is substantial in most geriatric settings. Well-designed, standardised studies evaluating exercise or nutrition interventions are needed before treatment guidelines can be developed. Physicians should screen for sarcopenia in both community and geriatric settings, with diagnosis based on muscle mass and function. Supervised resistance exercise is recommended for individuals with sarcopenia. EAA (with leucine) and HMB may improve muscle outcomes.

1 September 2018 in Journal of Atherosclerosis and Thrombosis
Verified
Journal Article
Open access
PDF file
MKMakoto Kinoshita
Makoto Kinoshita
KYKoutaro Yokote
Koutaro Yokote
HAHidenori Arai
Hidenori Arai
MIMami Iida
Mami Iida
YIYasushi Ishigaki
Yasushi Ishigaki
CAClinical Management of Atherosclerosis
Clinical Management of Atherosclerosis
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

1 March 2024 in Age and Ageing
Verified
Journal Article
Open access
PDF file
BKBen Kirk
Ben Kirk
PCPeggy Cawthon
Peggy Cawthon
HAHidenori Arai
Hidenori Arai
JAJosé Alberto AVILA-FUNES
José Alberto AVILA-FUNES
RBRocco Barazzoni
Rocco Barazzoni
ACAlfonso J Cruz-Jentoft
Alfonso J Cruz-Jentoft
Importance: Sarcopenia, the age-related loss of muscle mass and strength/function, is an important clinical condition. However, no international consensus on the definition exists. Objective: The Global Leadership Initiative in Sarcopenia (GLIS) aimed to address this by establishing the global conceptual definition of sarcopenia. Design: The GLIS steering committee was formed in 2019–21 with representatives from all relevant scientific societies worldwide. During this time, the steering committee developed a set of statements on the topic and invited members from these societies to participate in a two-phase International Delphi Study. Between 2022 and 2023, participants ranked their agreement with a set of statements using an online survey tool (SurveyMonkey). Statements were categorised based on predefined thresholds: strong agreement (>80%), moderate agreement (70–80%) and low agreement (<70%). Statements with strong agreement were accepted, statements with low agreement were rejected and those with moderate agreement were reintroduced until consensus was reached. Results: 107 participants (mean age: 54 ± 12 years [1 missing age], 64% men) from 29 countries across 7 continents/regions completed the Delphi survey. Twenty statements were found to have a strong agreement. These included; 6 statements on ‘general aspects of sarcopenia’ (strongest agreement: the prevalence of sarcopenia increases with age (98.3%)), 3 statements on ‘components of sarcopenia’ (muscle mass (89.4%), muscle strength (93.1%) and muscle-specific strength (80.8%) should all be a part of the conceptual definition of sarcopenia)) and 11 statements on ‘outcomes of sarcopenia’ (strongest agreement: sarcopenia increases the risk of impaired physical performance (97.9%)). A key finding of the Delphi survey was that muscle mass, muscle strength and muscle-specific strength were all accepted as ‘components of sarcopenia’, whereas impaired physical performance was accepted as an ‘outcome’ rather than a ‘component’ of sarcopenia. Conclusion and relevance: The GLIS has created the first global conceptual definition of sarcopenia, which will now serve to develop an operational definition for clinical and research settings.

1 October 2020 in Geriatrics & Gerontology International
Verified
Journal Article
Closed access
PDF file
SSShosuke Satake
Shosuke Satake
HAHidenori Arai
Hidenori Arai